Ozempic is synonymous with weight loss for many people. Doctors explain benefits and risks of semaglutide and other GLP-1 ...

GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small study. Here's what doctors have to say.

A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

For all the buzz surrounding weight loss medications like semaglutide and tirzepatide, these drugs aren’t perfect. They come with a risk of side effects like nausea and diarrhea ...

Company reported positive Phase 2b QUALITY study topline results for enobosarm + semaglutide (Wegovy®) with study meeting prespecified primary endpoint of preservation of lean mass as well as greater ...

Novo Nordisk's 2024 earnings exceeded estimates, with strong performance in diabetes, obesity, and rare disease segments.

A new study examines how cost, side effects and other factors influence whether people stop GLP-1s, while Noom cuts staff to ...

Novo Nordisk is under pressure from investors for more information about its next-generation obesity drug candidate CagriSema ...

Dear Carolyn: About a year ago, my mom started taking a semaglutide weight loss drug and has lost 75 pounds, which she’s proud of — and I’m happy for her! However, eating with her has become ...

Here are our top tips: Use an insulated cooler bag with ice packs to transport your weight loss medication. When flying, keep compounded semaglutide in your carry-on bag so you can better control ...

Wegovy is a GLP-1 agonist containing semaglutide ... Rybelsus found an average drop of 1 to 1.3% A1C in adults with a starting A1C of 8.3%. While Rybelsus is not a weight loss medication, the ...

Alexandra Sowa's new book The Ozempic Revolution is intended to be the "first comprehensive user guide" to GLP-1 drugs like Ozempic.